FORA Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,991
Closed -$403K 734
2022
Q4
$403K Buy
+10,991
New +$434K 0.07% 308
2021
Q3
Sell
-7,234
Closed -$647K 944
2021
Q2
$647K Buy
7,234
+5,842
+420% +$494K 0.12% 211
2021
Q1
$106K Buy
+1,392
New +$105K 0.03% 396
2020
Q3
Sell
-531
Closed -$31K 1071
2020
Q2
$31K Buy
+531
New +$28.5K 0.01% 739
2020
Q1
Sell
-2,398
Closed -$143K 1416
2019
Q4
$143K Buy
+2,398
New +$129K 0.01% 697

Other funds holding SYNH

FORA Capital's SYNH Position: Q1 2023 in Review

FORA Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 10,991 shares — an estimated $403K sold.

FORA Capital first reported a position in SYNH in Q4 2019 and held it in 5 quarters. The position peaked at $647K in Q2 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • FORA Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • FORA Capital sold 10,991 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $403K.
  • FORA Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 5 quarters.
  • FORA Capital's Syneos Health, Inc. Class A Common Stock position peaked at $647K in Q2 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on FORA Capital's 13F filing for Q1 2023, filed 12 May 2023.